COMPASS Pathways plc financial data

Symbol
CMPS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Rd Floor, 1 Ashley Road, Altrincham, Chesire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Compass Rx Ltd. (to 8/10/2020)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.45K % +29.9%
Debt-to-equity 20.5 % +43%
Return On Equity -57.7 % +0.24%
Return On Assets -47.9 % +5.36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.4M shares +49.4%
Common Stock, Shares, Outstanding 68.4M shares
Entity Public Float 216M USD -12.7%
Common Stock, Value, Issued 699K USD
Weighted Average Number of Shares Outstanding, Basic 68.4M shares +50%
Weighted Average Number of Shares Outstanding, Diluted 68.4M shares +50%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 103M USD +41.3%
General and Administrative Expense 51.7M USD +4.38%
Operating Income (Loss) -154M USD -26.3%
Nonoperating Income (Expense) 16M USD -23.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -138M USD -36.6%
Income Tax Expense (Benefit) 854K USD +59.3%
Net Income (Loss) Attributable to Parent -139M USD -36.7%
Earnings Per Share, Basic -2.24 USD/shares +4.68%
Earnings Per Share, Diluted -2.24 USD/shares +4.68%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 229M USD +54.2%
Other Assets, Current 2.7M USD +25.5%
Assets, Current 265M USD +36.9%
Deferred Income Tax Assets, Net 4.02M USD +31.7%
Property, Plant and Equipment, Net 359K USD -41.3%
Operating Lease, Right-of-Use Asset 3.18M USD -33.5%
Other Assets, Noncurrent 6.24M USD -16.2%
Assets 279M USD +32.7%
Accounts Payable, Current 8.2M USD +313%
Employee-related Liabilities, Current 3.12M USD +4.81%
Liabilities, Current 22M USD +72.4%
Operating Lease, Liability, Noncurrent 799K USD -68.5%
Liabilities 52.3M USD +20.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16.9M USD -0.92%
Retained Earnings (Accumulated Deficit) -453M USD -44.4%
Stockholders' Equity Attributable to Parent 226M USD +36%
Liabilities and Equity 279M USD +32.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD +24.9%
Net Cash Provided by (Used in) Financing Activities 63.5M USD +5786%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 68.4M shares
Common Stock, Shares, Issued 68.4M shares
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 42.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 229M USD +54.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 765K USD
Deferred Tax Assets, Valuation Allowance 76.1M USD +46.5%
Deferred Tax Assets, Gross 79.5M USD +46.5%
Operating Lease, Liability 3.72M USD +144%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -139M USD -35.2%
Lessee, Operating Lease, Liability, to be Paid 3.99M USD +148%
Property, Plant and Equipment, Gross 1.15M USD +51.7%
Operating Lease, Liability, Current 2.39M USD +9.61%
Lessee, Operating Lease, Liability, to be Paid, Year Two 227K USD +1.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.81M USD +568%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +33.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 274K USD +230%
Lessee, Operating Lease, Liability, to be Paid, Year Three 96K USD +74.5%
Deferred Tax Assets, Operating Loss Carryforwards 64.7M USD +46.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95K USD +75.9%
Operating Lease, Payments 628K USD +11.7%
Additional Paid in Capital 695M USD +40.1%
Depreciation, Depletion and Amortization 61K USD +27.1%
Share-based Payment Arrangement, Expense 18.7M USD +21%
Interest Expense 1.1M USD